ORGO FY 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$193M

Gross Profit

$125M64.4% margin

Operating Income

-$52M-26.7% margin

Net Income

-$65M-33.5% margin

EPS (Diluted)

$-0.94

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$63M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$164M

Total Liabilities

$117M

Stockholders' Equity

$47M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$193M	$0	—
Gross Profit	$125M	-$5M	+2814.4%
Operating Income	-$52M	-$5M	-1022.8%
Net Income	-$65M	-$2M	-2996.2%